Voloridge Investment Management
EPZM

Voloridge Investment Management’s Epizyme, Inc EPZM Stock Holding History

Voloridge Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-107,566
Closed -$551K – 1931
2021
Q3 		$551K Sell
107,566
-126,024
-54% -$765K ﹤0.01% 1441
2021
Q2 		$1.94M Sell
233,590
-72,612
-24% -$612K 0.01% 997
2021
Q1 		$2.67M Buy
306,202
+122,270
+66% +$1.27M 0.02% 715
2020
Q4 		$2M Buy
+183,932
New +$2.27M 0.02% 738
2020
Q2 		– Sell
-43,923
Closed -$681K – 1586
2020
Q1 		$681K Buy
+43,923
New +$943K 0.02% 620

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Voloridge Investment Management's EPZM Position: Q4 2021 in Review

Voloridge Investment Management sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 107,566 shares — an estimated $551K sold.

Voloridge Investment Management first reported a position in EPZM in Q1 2020 and held it in 5 quarters. The position peaked at $2.67M in Q1 2021. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.

  • Voloridge Investment Management reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 107,566 Epizyme, Inc shares in Q4 2021, an estimated $551K.
  • Voloridge Investment Management first reported a position in Epizyme, Inc in Q1 2020 and held it in 5 quarters.
  • Voloridge Investment Management's Epizyme, Inc position peaked at $2.67M in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.